Clinical Trial Update: Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir

View source ↗

Summary

This Clinical Trial Update discusses a study evaluating the early occurrence of hepatocellular carcinoma in Egyptian patients infected with hepatitis C who are …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• Daclatasvir (daclatasvir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: MTI University | Conditions: Hepatitis C | Status: UNKNOWN